Sanofi SA (SAN)
Euronext
Real-time Data
07:00 AM
Day's Range
77.1952 wk Range
71.25Overview - SAN - Sanofi SA
Key Statistics
Valuation
Enterprise Value
110.78B
P/E (Trailing)
‪24.36‬
P/E (Forward)
‪8.70‬
PEG Ratio
‪8.70‬
Price / Sales (TTM)
‪1.93‬
Price / Book
‪1.36‬
EV / EBITDA
‪8.18‬
Profitability
Gross Margin
‪75.47%‬
Profit Margin
‪8.09%‬
Operating Margin
‪21.03%‬
Return on Assets
‪5.09%‬
Return on Equity
‪5.70%‬
Ownership
Shares Outstanding
1.21B
Float
1.08B
Held by Insiders
‪10.31%‬
Held by Institutions
‪42.85%‬
Price stats
Beta
‪0.27‬
50-Day Avg
‪75.68‬
200-Day Avg
‪79.06‬
Dividends
Payout Ratio
‪127.16%‬
Frequency
Annual
Analyst Consensus
24 analysts
Average price target
‪€ 94.28‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - SAN - Sanofi SA
Peers - SAN - Sanofi SA
Peer Comparison
Compared with companies in Footwear & Accessories listed on Euronext.
- SANEuronextSanofi SA94.57BMarket Cap-9.27%52-week change24.36P/E (Trailing)‪8.09%‬Profit Margin
- ELIEuronextElia Group SA/NV13.67BMarket Cap+21.59%52-week change22.28P/E (Trailing)‪13.89%‬Profit Margin
- ALDLTEuronextDelta Plus Group S.A.261.67MMarket Cap-37.53%52-week change9.53P/E (Trailing)‪6.99%‬Profit Margin
- CHSREuronextChaussia Inc.3.36MMarket Cap+0.00%52-week change63.64P/E (Trailing)‪3.20%‬Profit Margin
Profile Summary - SAN - Sanofi SA
About
Sanofi SA is a French multinational pharmaceutical and healthcare company headquartered in Paris, renowned for its research, development, manufacturing, and marketing of innovative medicines and vaccines. Established in 1973, it has evolved through key mergers, including with Synthélabo in 1999 and Aventis in 2004,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
